SCHEMBL9923883

SCHEMBL9923883

Cc1c(N)nc2ccccn12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
GAA P10253 4/20 0.53
DAPK3 O43293 1/20 0.53
JAK2 O60674 1/20 0.53
PRKD3 O94806 1/20 0.53
MAP4K4 O95819 1/20 0.53
ABL1 P00519 1/20 0.53
CSF1R P07333 1/20 0.53
RET P07949 1/20 0.53
MET P08581 1/20 0.53
PDGFRA P16234 1/20 0.53
PRKACA P17612 1/20 0.53
LTK P29376 1/20 0.53
GRK5 P34947 1/20 0.53
KDR P35968 1/20 0.53
MAPK8 P45983 1/20 0.53
MAPK9 P45984 1/20 0.53
CSNK1A1 P48729 1/20 0.53
CDK8 P49336 1/20 0.53
CLK2 P49760 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL266148 0.79 KMT2A (0.58) ALDH1A1GAAKDM4ENPC1GLA
SCHEMBL26359012 0.78 ALDH1A1 (0.54) ALDH1A1GAAKDM4ENPC1GLA
SCHEMBL25889552 0.76 ALDH1A1 (0.52) ALDH1A1GAAKDM4ENPC1GLA
SCHEMBL14685183 0.76 KDM4E (0.56) ALDH1A1GAAKDM4ENPC1GLA
SCHEMBL16563652 0.76 KMT2A (0.54) ALDH1A1GAAKDM4ENPC1GLA
SCHEMBL24242364 0.76 KDM4E (0.52) ALDH1A1GAADAPK3JAK2PRKD3
SCHEMBL19700040 0.76 KDM4E (0.52) ALDH1A1GAADAPK3JAK2PRKD3
SCHEMBL8829992 0.76 ALDH1A1 (0.52) ALDH1A1GAAKDM4ENPC1GLA
SCHEMBL18459077 0.76 ALDH1A1 (0.52) ALDH1A1GAAKDM4ENPC1GLA
SCHEMBL20989729 0.76 DAPK3 (0.49) ALDH1A1GAADAPK3JAK2PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3333168-B1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-01-26 EP disclosed
EP-3214153-B1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2020-03-25 EP disclosed
EP-2894157-B1 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO LTD (KR) 2018-04-04 EP disclosed
WO-2017214269-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2017-12-14 WO disclosed
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 ALDH1A1 2230/4885GAA 2699/4885DAPK3 1170/4885
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 ALDH1A1 2230/4885GAA 2699/4885DAPK3 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.